Advertisement

Topics

ES Cell International Party Limited Company Profile

13:30 EST 12th December 2018 | BioPortfolio

ES Cell International Pte Ltd is a regenerative medicine company aiming to be a world leading provider of products and technologies derived from human embryonic stem (hES) cells.

ES Cell International controls significant platform technology due to its intellectual property and know-how in the area of hES cells and their directed differentiation.



ES Cell International is one of 10 groups whose hES cells are listed on the US National Institute of Health (NIH) Stem Cell Registry. This listing means that research partners who access ES Cell International's cells are eligible to apply for a share of $480 million (US) in funding.



ES Cell International has assembled a world-class research and management team to best capitalise on the opportunities derived from hES cell technology. The 7 strong management team is made up of authorities in their field with significant experience from around the world. The team includes a Director of Molecular and Genomic Discovery, based in Melbourne, and a Chief Scientific Officer based in Singapore.

Location

PO Box 6492
Melbourne
VIC
8008
Australia

Contact

Phone: +61 3 8532 1777
Fax: +61 3 8532 1771
Email: jschmitt@escellinternational.com


News Articles [1822 Associated News Articles listed on BioPortfolio]

Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates

This week brought a sobering reminder of how far away we are from true gender equality in the life sciences. An industry party held during BIO’s annual meeting in Boston last week featured scantily ...

International Stem Cell (ISCO) - Third cohort ready to go

Edison Investment Research - Pharmaceutical & healthcare - International Stem Cell : International Stem Cell (ISCO) recently announced that the data safety monitoring board for its Phase I trial of IS...

International Stem Cell to Launch Advanced Joint Supplement

International Stem Cell (OTCQB:ISCO) a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that the Company plans ...

International Stem Cell (ISCO) - Biomedical sales more than double

Edison Investment Research - Pharmaceutical & healthcare - International Stem Cell : International Stem Cell (ISCO) reported Q218 revenues of $3.0m, up 72.4% compared to Q217 mainly due to the biomedi...

Study shows for the first time how a specific cell gene affects transformation of others

An international team of seven institutions from Spain and the US including the University of Valencia has discovered for the first time that the biological activity of the c-MYC gene is necessary so ...

International Stem Cell (ISCO) - Strong biomedical sales and new clinical data

Edison Investment Research - Pharmaceutical & healthcare - International Stem Cell : International Stem Cell (ISCO) reported Q318 revenues of $3.2m, up 73.0% compared to Q317 mainly due to the biomedi...

Solentim Wins Two Queen’s Awards for Enterprise

Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation Wimborne, UK, 8th October 2018 / Sciad Newswire / Solentim...

VHIO is the first Spanish site to conduct CAR T cell trial against lymphoma in Europe

(Vall d'Hebron Institute of Oncology) Launched: First international clinical trial with CAR T cell therapy for patients with aggressive B-cell non-Hodgkin lymphoma (B-Cell NHL) in Europe.The trial has...

PubMed Articles [4137 Associated PubMed Articles listed on BioPortfolio]

Changes in political party systems arising from conflict and transfer among political parties.

Conflict that arises between two groups of different paradigms is an inevitable phenomenon, and a representative example of the conflict among different groups is a conflict phenomenon caused by compe...

A survey of public attitudes towards third-party reproduction in Japan in 2014.

The objective of this study was to examine public attitudes towards third-party reproduction and the disclosure of conception through third-party reproduction.

Cortical processing of location changes in a "cocktail-party" situation: Spatial oddball effects on electrophysiological correlates of auditory selective attention.

Neural mechanisms of selectively attending to a sound source of interest in a simulated "cocktail-party" situation, composed of multiple competing sources, were investigated using event-related potent...

Developing a Third-Party Analytics Application Using Australia's National Personal Health Records System: Case Study.

My Health Record (MyHR) is Australia's national electronic health record (EHR) system. Poor usability and functionality have resulted in low utility, affecting enrollment and participation rates by bo...

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.

The treatment of patients with Hodgkin lymphoma (HL) who develop disease progression after undergoing allogeneic stem cell transplantation (allo-SCT) remains challenging.

Clinical Trials [7572 Associated Clinical Trials listed on BioPortfolio]

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

Primary Objective: 1. To determine the maximally tolerated dose of anti-third party cytolytic T-lymphocytes, defined as the dose which achieve engraftment without severe GVHD (graft-vs-h...

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

To assess the safety and biological efficacy of therapeutically administered most closely HLA-matched third party donor-derived specific cytotoxic T lymphocytes (CTLs) targeting cytomegalo...

Adverse Event Data Collection From External Registries on Nonacog Beta Pegol

The purpose of this study is to collect data on adverse events from third party registries that include information about adverse events from patients with haemophilia B treated with nonac...

Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

The objective of this trial is to assess the toxicity of thymus transplantation following unrelated umbilical cord blood transplantation. Emphasis will be placed on adverse events that ar...

Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

This study is testing to see how well transfusions of T-cells work in treating Epstein-Barr Virus (EBV). These T-cells are made from the blood of normal donors who are immune to EBV. A tra...

Companies [2618 Associated Companies listed on BioPortfolio]

ES Cell International Party Limited

ES Cell International Pte Ltd is a regenerative medicine company aiming to be a world leading provider of products and technologies derived from human embryonic stem (hES) cells. ES Cell International...

Genea Stem Cells Pty Ltd

Genea Stem Cells Pty Ltd is a subsidiary of Genea Limited (formerly Sydney IVF Limited), a public, unlisted company that has been operating IVF clinics in Australia since 1985. Genea Stem Cells Pty ...

Cryo-Cell International, Inc.

Based in Oldsmar, Florida, with over 200,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-C...

Party City

Party City Corporation is America's largest specialty party goods chain and the country's premier Halloween specialty retailer. Party City operates more than 600 company-owned and franchise stores thr...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "ES Cell International Party Limited" on BioPortfolio

We have published hundreds of ES Cell International Party Limited news stories on BioPortfolio along with dozens of ES Cell International Party Limited Clinical Trials and PubMed Articles about ES Cell International Party Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ES Cell International Party Limited Companies in our database. You can also find out about relevant ES Cell International Party Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record